Intrexon - Top 15 Biotech VC Deals of 2010

Company: Intrexon
Based: Blacksburg, VA
Amount: $37.51M

Investors: New River Management funds, managed by Third Security and NewVa Capital Partners, and other investors.

Scoop: To fund its modular DNA control systems, Intrexon closed another round of Series D financing, enlisting the help of 65 investors in the process. And after raising another $1 million this month, the company has nearly $130 million to continue working on its technology. The company also recently acquired a North Carolina biotech, Agarigen, for its mushroom-based expression platform for the rapid, high yield production of recombinant proteins.

Intrexon - Top 15 Biotech VC Deals of 2010

Suggested Articles

Pillar is bankrolling a new accelerator for budding biotechs. Petri aims to serve biotech startups at the “frontier of biology and engineering.”

One of the last major, late-stage attempt at stopping Alzheimer’s using a BACE inhibitor has ended up on the trash pile with so many others.

The oligosaccharide microbiome modulator was no better than placebo at reducing lactose intolerance symptoms.